These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26673998)

  • 1. Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism.
    Lin S; Lei K; Du W; Yang L; Shi H; Gao Y; Yin P; Liang X; Liu J
    Int J Biochem Cell Biol; 2016 Feb; 71():24-34. PubMed ID: 26673998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic reticulum-targeting photosensitizer Hypericin confers chemo-sensitization towards oxaliplatin through inducing pro-death autophagy.
    Lin S; Yang L; Shi H; Du W; Qi Y; Qiu C; Liang X; Shi W; Liu J
    Int J Biochem Cell Biol; 2017 Jun; 87():54-68. PubMed ID: 28392376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells.
    Šemeláková M; Mikeš J; Jendželovský R; Fedoročko P
    J Photochem Photobiol B; 2012 Dec; 117():115-25. PubMed ID: 23099482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of
    Halaburková A; Jendželovský R; Kovaľ J; Herceg Z; Fedoročko P; Ghantous A
    Clin Epigenetics; 2017; 9():62. PubMed ID: 28603560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
    Wang X; Guo Y; Yang S; Wang C; Fu X; Wang J; Mao Y; Zhang J; Li Y
    J Pharmacol Exp Ther; 2010 Sep; 334(3):847-53. PubMed ID: 20551295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin.
    Mikešová L; Mikeš J; Kovaľ J; Gyurászová K; Culka L; Vargová J; Valeková B; Fedoročko P
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):470-83. PubMed ID: 24284100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
    Hu J; Song J; Tang Z; Wei S; Chen L; Zhou R
    Eur J Pharmacol; 2021 Jun; 900():174071. PubMed ID: 33811836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy.
    Jendželovský R; Jendželovská Z; Kuchárová B; Fedoročko P
    Biomed Pharmacother; 2019 Jan; 109():2173-2181. PubMed ID: 30551474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells.
    Šemeláková M; Jendželovský R; Fedoročko P
    Biomed Pharmacother; 2016 Jul; 81():38-47. PubMed ID: 27261575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diverse roles of glutathione-associated cell resistance against hypericin photodynamic therapy.
    Theodossiou TA; Olsen CE; Jonsson M; Kubin A; Hothersall JS; Berg K
    Redox Biol; 2017 Aug; 12():191-197. PubMed ID: 28254657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer.
    Khot MI; Perry SL; Maisey T; Armstrong G; Andrew H; Hughes TA; Kapur N; Jayne DG
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():221-229. PubMed ID: 29969677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.
    Temmink OH; Hoebe EK; van der Born K; Ackland SP; Fukushima M; Peters GJ
    Br J Cancer; 2007 Jan; 96(2):231-40. PubMed ID: 17242697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
    Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines.
    Arnould S; Hennebelle I; Canal P; Bugat R; Guichard S
    Eur J Cancer; 2003 Jan; 39(1):112-9. PubMed ID: 12504667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility of primary cultured human skin cells to hypericin PDT in an in vitro model.
    Popovic A; Wiggins T; Davids LM
    J Photochem Photobiol B; 2015 Aug; 149():249-56. PubMed ID: 26114219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.
    Barathan M; Mariappan V; Shankar EM; Abdullah BJ; Goh KL; Vadivelu J
    Cell Death Dis; 2013 Jun; 4(6):e697. PubMed ID: 23807226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
    Xu L; Zhang X; Cheng W; Wang Y; Yi K; Wang Z; Zhang Y; Shao L; Zhao T
    Retrovirology; 2019 Feb; 16(1):5. PubMed ID: 30782173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
    Gyurászová K; Mikeš J; Halaburková A; Jendželovský R; Fedoročko P
    Photochem Photobiol Sci; 2016 Jun; 15(6):812-21. PubMed ID: 27241169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p38 MAPKs in hypericin photodynamic therapy-induced apoptosis of nasopharyngeal carcinoma cells.
    Chan PS; Koon HK; Wu ZG; Wong RN; Lung ML; Chang CK; Mak NK
    Photochem Photobiol; 2009; 85(5):1207-17. PubMed ID: 19496992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.